Severe acute respiratory syndrome coronavirus 2 targeted antibodies cocktail and B cell receptor interplay: interventions to trigger vaccine development

Severe acute respiratory syndrome coronavirus 2 targeted antibodies cocktail and B cell receptor interplay: interventions to trigger vaccine development

Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2 spread globally and creates an alarming situation. Following the SARS-CoV-2 paradigm, therapeutic efficacy is achieved via repurposing several antiviral, antibacterial, and antimalarial drugs. In...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kabeer Haneef, Rabia Saleem, Muhammad Saleem Iqbal Khan, Olawale Samuel Adeyinka, Sadeeq Banday, Muhammad Umer Asghar, Zia Ur Rahman, Zainab Fatima
Formato: article
Lenguaje:EN
Publicado: Open Exploration Publishing Inc. 2021
Materias:
severe acute respiratory syndrome coronavirus 2
humoral immunity
b cell receptor
vaccine production
adaptive immunity
antibody pathogenesis
cytokine responses
non-structural protein
Immunologic diseases. Allergy
RC581-607
Acceso en línea:https://doaj.org/article/384630a1f78d4c3098b31044bc0772de
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares